The University of Kansas Hospital Authority is suing CVS over alleged diversion of $62 million in drug savings. The University of Kansas Hospital Authority is suing CVS and its subsidiaries, alleging the mega pharmacy company fraudulently diverted nearly $62 million in prescription drug savings. A lawsuit alleges money from the federal 340B program was pocketed by CVS between 2020 and 2025. “Defendants’ fraudulent scheme was knowingly and intent…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.